• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Rep. Elijah Cummings, D-Md., and Rep. Peter Welch, D-Vt., who met with President Trump earlier this year over tackling drug prices, are dismayed at the lack of action from the White House. (AP Photo/Pablo Martinez Monsivais)
    Healthcare

    House Democrats slam Trump ‘betrayal’ on drug prices

    Robert King -
    June 21, 2017 3:00 pm
    0
    This is the first time the FDA has taken steps to take a prescription painkiller off the market because of its risk for addiction. (AP Photo/Chris Post)
    Healthcare

    An FDA first: Agency asks drug company to take its opioid off the market

    Kimberly Leonard -
    June 8, 2017 9:34 pm
    0
    One of the moves Congress and the FDA are looking at is a loophole that major pharmaceutical companies use to stop generic makers from creating a cheaper copy.
    Healthcare

    FDA takes bigger role in lowering drug prices

    Robert King -
    June 5, 2017 4:01 am
    0
    The pharmaceutical giant has raised prices an average of 20 percent this year. (AP Photo/Richard Drew, File)
    Healthcare

    Pfizer hikes price on nearly 100 drugs, report says

    Robert King -
    June 2, 2017 7:57 pm
    0
    Representatives of drugmaker Mylan, which produces the allergy drug EpiPen, wants to meet with Sen. Chuck Grassley to discuss a subpoena threat over documents pertaining to Medicaid's rebate program. (AP Photo/Rich Pedroncelli, File)
    Healthcare

    EpiPen maker seeks meeting with Chuck Grassley over subpoena threat, report says

    Robert King -
    June 2, 2017 2:31 pm
    0
    In the last several years, stories of collusion, price gouging and cover-ups by industry executives have continued to unfold -- all designed to improve their bottom line at the expense of patients. (AP Photo/Mel Evans)
    Beltway Confidential

    4 ways Congress can put the brakes on rising pharmaceutical drug costs

    Kevin Campbell -
    June 1, 2017 4:17 pm
    0
    The HHS inspector general's office found that the government overpaid about $1.27 billion for the allergy antidote under the Medicaid rebate program. (AP Photo/Rich Pedroncelli, File)
    Healthcare

    Grassley: Mylan fleeced taxpayers $1.27 billion for EpiPen

    Robert King -
    May 31, 2017 7:38 pm
    0
    A group of lawmakers are arguing that forcing drugmakers to explain their reason for charging so much for drugs could lead to major reforms in lowering prices. (AP photo/Shawn Poynter)
    Healthcare

    Lawmakers seek transparency on drug prices

    Robert King -
    May 16, 2017 2:01 pm
    0
    Sens. Chuck Grassley, R-Iowa, Amy Klobuchar, D-Minn., and John McCain, R-Ariz., wrote Trump budget director Mick Mulvaney asking the administration to lower high drug prices. (AP Photo/Rich Pedroncelli)
    Healthcare

    Senators push Trump administration move on high drug prices

    Robert King -
    May 15, 2017 5:17 pm
    0
    The majority of Americans want elected officials to take action to lower prescription drug prices. (AP Photo/Rich Pedroncelli)
    Healthcare

    Americans agree on healthcare

    greg-strimple, David Mitchell -
    May 12, 2017 4:04 am
    0
    1...108109110...156Page 109 of 156
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.